Guangzhou Jeep Biotechnology JEEP
Finnrick has tested 47 samples from Guangzhou Jeep Biotechnology JEEP across 4 products.
Take Action
Request Full Data Access to the Finnrick database of peptide tests.
Products
| Tests | ||||||||
|---|---|---|---|---|---|---|---|---|
| Product | Rating | Count | Avg | Min | Max | Oldest | Most Recent | |
| GHK-Cu | 5 | 23 Oct 2025 | 13 Jul 2026 | |||||
| Tirzepatide | 15 | 14 Oct 2025 | 4 Aug 2026 | |||||
| Retatrutide | 21 | 14 Nov 2025 | 12 Aug 2026 | |||||
| Tesamorelin | 4 | 25 Nov 2025 | 9 Aug 2026 | |||||
The Guangzhou Jeep Biotechnology JEEP samples tested by Finnrick were either acquired by Finnrick directly, or submitted by the public.
Customer Reviews
These indicators of customer satisfaction are based on reports submitted by the public through the Finnrick testing program, and are not verified.
Based on 22 overall satisfaction reports
People who submitted test requests to Finnrick gave Guangzhou Jeep Biotechnology JEEP an average satisfaction rating of 4.7 out of 5 across 22 reports associated with samples received and tested by Finnrick. Customers rated ease of purchase (4.2/5) and payment methods (3.8/5) comparatively lower.
Most recent Guangzhou Jeep Biotechnology JEEP tests
Samples are tested in commercial labs
tests
products
Scores
First
Last
| Quantity | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Product | Certificate | Test Score | Label | Tested | Difference | Purity | Endotoxins | Batch ID | Container | Tested At | Sent By |
| 12 Aug 2026 | Retatrutide | View | 40mg | 34.9mg | -12.8% | 99.90% | low | JP20260002 | (no data) | Lab E | Public | |
| 12 Aug 2026 | Retatrutide | View | 30mg | 20.9mg | -30.3% | 93.80% | not detected | Jp20260017 | No label, Silver crimp, Pink cap | Lab E | Public | |
| 9 Aug 2026 | Tesamorelin | View | 10mg | 11.4mg | +14.0% | 99.70% | n/a | LOT:TS10BT MFG:06/01/2026 EXP:06/01/2028 | No label / Silver crimp / Black cap | Lab G | Public | |
| 5 Aug 2026 | Retatrutide | View | 30mg | 26.3mg | -12.3% | 99.90% | n/a | JP20260017 | (no data) | Lab E | Public | |
| 4 Aug 2026 | Tirzepatide | View | 20mg | 20mg | 99.90% | low | LOT:TR20BLT MFG:06/01/2026 EXP:06/01/2028 | No label / Silver crimp / Blue cap | Lab E | Public | ||
| 4 Aug 2026 | Retatrutide | View | 10mg | 9.87mg | -1.3% | 99.30% | low | LOT:RT10PT MFG:06/01/2026 EXP:06/01/2028 | No label / Silver crimp / Pink cap | Lab E | Public | |
| 3 Aug 2026⚠️ | Retatrutide | View | Endotoxins | 30mg | n/a | n/a | n/a | low | JP20260017 | No label, Silver crimp, Pink cap | Lab G | Public |
About Guangzhou Jeep Biotechnology JEEP Test Results From Finnrick
Guangzhou Jeep Biotechnology JEEP is a peptide vendor with multiple products tracked in the independent testing dataset collected by Finnrick. This page compiles recent, batch-level test results across 4 products and 47 tests, including scores, test dates, batch IDs, and lab details. This enables you to compare quality over time, not just marketing claims.
Each tested sample receives a 0–10 score, with 10 being the best possible value. It is the total of three components: purity (0–4 points), quantity accuracy vs. the label or batch claim (0–4 points), and batch information quality (0–2 points).
When several test results are available for a product and vendor pair, you’ll also find a Finnrick Rating (A–E, where A is best and E is worst, X if an insufficient number of tests is available, or F in rare cases of documented and widespread fraud) and customer satisfaction reports with sub-scores that provide additional context. Use the table above to review purity, quantity accuracy, consistency between batches, and any notable outliers surfaced in Finnrick testing data.
Guangzhou Jeep Biotechnology JEEP Testing Activity & Score Summary
In the past 30 days, Finnrick has published 8 new test results for Guangzhou Jeep Biotechnology JEEP, and 17 in the past three months. The overall dataset includes 47 tested samples with an average score of 8.0/10 across all products.
Across 45 identity-tested samples, 100% were confirmed to contain the expected peptide (identity pass rate). Among those that passed, median purity was 99.9%. Approximately 93% of passing samples tested at or above 98% purity.
Here is a closer look at the most frequently tested products (top 3):
- Retatrutide (21 tests, 100% identity pass, median purity 99.9%) — Test scores are highly variable, ranging from 3.8 to 10.0 (average 8.2/10), suggesting significant batch-to-batch differences.
- Tirzepatide (15 tests, 100% identity pass, median purity 99.9%) — Test scores are highly variable, ranging from 5.5 to 10.0 (average 8.8/10), suggesting significant batch-to-batch differences.
- GHK-Cu (5 tests, 100% identity pass, median purity 99.9%) — Scores are tightly clustered between 6.0 and 7.0, indicating consistent quality across batches.